地塞米松对糖尿病大鼠视网膜血管内白细胞聚集、血管通透性及细胞问黏附因子-1表达的影响
Effect of dexamethasone on retinal leukocyte accumulation, vascular permeability, and the expression of intercelluar adhension molecule -1 in experimental diabetic retinopathy
查看参考文献15篇
|
文摘
|
目的：探讨糖尿病大鼠玻璃体腔注射地塞米松对视网膜血管内白细胞聚集、血管通透性及细胞间黏附因子（ICAM）-1表达的影响。方法：72只Brown—Norway大鼠分为对照组、糖尿病组、糖尿病＋生理盐水组和糖尿病＋地塞米松组共4组，每组各18只大鼠。除对照组外其余大鼠行链脲佐菌素腹腔注射制造糖尿病模型。糖尿病＋生理盐水和糖尿病＋地塞米松组大鼠玻璃体腔分别注射10μl生理盐水和10／11地塞米松（5μg／ml）。用吖啶橙血管造影和伊文思蓝方法分别检测白细胞聚集和血管通透性改变情况。以荧光定量多聚酶链式反应和酶联免疫吸附实验检测视网膜中ICAM-1的表达。结果：注射地塞米松后，大鼠视网膜血管内白细胞聚集减少，血管通透性降低，ICAM-1表达减少。4组大鼠视网膜ICAM-1mRNA和蛋白量分别为0．434±0．07、0．764±0．21、0．74±0．18、0．55±0．13和（37．90±4．56）、（76．74±6．68）、（74．32±7．11）、（39．61±4．47）pg／mg。结论：地塞米松能减少糖尿病大鼠视网膜血管内白细胞聚集，降低血视网膜屏障通透性。其机制可能是通过其抑制ICAM-1的表达起作用。 |
|
其他语种文摘
|
Objective To investigate the effect of intravitreal injection with dexamethasone on leukocyte accumulation, vascular permeability, and the expression of intercellular adhension molecule （ICAM-1） in rats with diabetes. Methods Seventy-two BN rats were divided into 4 groups： control group, diabetes group, diabetes ＋ physiologic saline group, and diabetes＋ dexamethasone group, with 18 rats in each group. Streptozotocin was injected into the rats to set up the diabetic model. Accumulated leukocytes were counted in vivo by acridine orange leukocyte fluorography, and retinal vascular permeability was measured by Evans blue assay. The expression of mRNA and protein level of ICAM-1 were evaluated by real-time quantitative polymerase chain reaction analysis and enzymedinked immunosorbent assay. Results In the diabetes＋ dexamethasone group, accumulated leukocytes were reduced, retinal vascular permeability decreased, and the expression of ICAM-1 decreased. The expression of ICAM-1 mRNA and protein levels in control group, diabetes group, diabetes ＋ physiologic saline group, and diabetes＋ dexamethasone group were 0. 43±0. 07,0. 76±0.21,0.74±0.18,and 0. 55±0. 13; （37. 90±4. 56）, （76.74±6.68）, （74.32±7.11）, and （39.61±4.47） pg/mg respectively. Conclusions Dexamethasone can reduce accumulated leukocytes and retinal vascular permeability, which may be caused by inhibiting the expression of ICAM-1. |
|
来源
|
中华眼底病杂志
,2007,23(4):273-276 【扩展库】
|
|
关键词
|
糖尿病视网膜病变／病因学
;
糖尿病视网膜病变／病理生理学
;
血视网膜屏障／病理生理学
;
细胞黏附分子
;
地塞米松／治疗应用
|
|
地址
|
1.
首都医科大学附属北京友谊医院眼科, 100050
2.
中国科学院心理学研究所
|
|
语种
|
中文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
1005-1015 |
|
学科
|
眼科学;药学 |
|
文献收藏号
|
CSCD:2955448
|
参考文献 共
15
共1页
|
|
1.
Nishiwaki H. Quantitative evaluation of leukocyte dynamics in retinal microcirculation.
Invest Ophthalmol Vis Sci,1995,36:123-130
|
被引
2
次
|
|
|
|
|
2.
Miyamoto K. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule 1 inhibition.
Proc Natl Acad Sci USA,1999,96:10836-10841
|
被引
34
次
|
|
|
|
|
3.
Miyamoto K. Vascular endothelial growth factor(VEGF)induced retinal vascular permeability is mediated by intercellular adhesion molecule 1(ICAM 1).
AmJ Pathol,2000,156:1733-1739
|
被引
10
次
|
|
|
|
|
4.
Xu Q. Sensitive blood-retinal barrier breakdown quantitation using Evans hlue.
Invest Ophthalmol Vis Sci,2001,42:789-794
|
被引
28
次
|
|
|
|
|
5.
Joussen AM. Retinal vascular endothelial growth factor induces intercellular adhesion molecule 1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
Am J Pathol,2002,160:501-509
|
被引
18
次
|
|
|
|
|
6.
McLeod DS. Enhanced expression of intracellular adhesion molecule-1 and P selectin in the diabetic human retina and choroid.
Am J Pathol,1995,147:642-653
|
被引
20
次
|
|
|
|
|
7.
Miyahara S. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.
Am J Pathol,2004,164:1697-1706
|
被引
8
次
|
|
|
|
|
8.
Joussen AM. Leukocyte-mediated endothelial cell injury and death in the diabetic retina.
Am J Pathol,2001,158:147-152
|
被引
32
次
|
|
|
|
|
9.
Felinski EA. Glucocorticoid regulation of endothelial cell tight junction gene expression:novel treatments for diabetic retinopathy.
Curr Eye Res,2005,30:949-957
|
被引
3
次
|
|
|
|
|
10.
Massin P Audren F. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema:preliminary results of a prospective controlled trial.
Ophthalmology,2004,111:218-224
|
被引
1
次
|
|
|
|
|
11.
Tamura H. lntravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Invest Ophthalmol Vis Sci,2005,46:1440-1444
|
被引
13
次
|
|
|
|
|
12.
Pe'er J. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Br J Ophthalmol,1996,80:241-245
|
被引
15
次
|
|
|
|
|
13.
Joussen AM. Suppression of Fas-Fasl. induced endothelial cell apoptosis prevents diabetic blood retinal barrier breakdown in a model of streptozotocin-induced diabetes.
EMBO J,2003,11:117-123
|
被引
1
次
|
|
|
|
|
14.
Kim I. Vaseular endothelial growth factor expression of intercellular adhesion molecule 1(ICAM-1), vascular cell adhesion molecule 1(VCAM-1), and Eselectin through nuclear factor kappa B activation in endothelial cells.
J Biol Chem,2001,276:7614-7620
|
被引
30
次
|
|
|
|
|
15.
Penfold PL. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule 1(ICAM-1)expression of the ECV301 cell line:implications for macular degeneralion.
Clin Exp Immunol,2000,121:458-465
|
被引
8
次
|
|
|
|
|
了解气象卫星更多信息，请访问